Case report: Crigler-Najjar syndrome type 1 in Croatia—more than a one in a million: a case series
Frontiers in Pediatrics · 19.10.2023 · 11
DOI: 10.3389/fped.2023.1276349 ↗Kurz gefasst
Fallbericht in der Zeitschrift Frontiers in Pediatrics, online erschienen am 19.10.2023. Verfasst von Matea Kovačić Perica und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, University Hospital Center Zagreb, Zagreb, Croatia. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Crigler-Najjar syndrome (CNS) is an exceedingly rare autosomal recessive disease with an estimated incidence of 1 in a million live births. CNS type 1 (CNS1) is the most severe form, characterized by severe unconjugated hyperbilirubinemia since birth due to the absence of hepatic uridine 5'-diphosphate glucuronyltransferase (UGT1A1) activity. Daily phototherapy (PT) and liver transplant (LT) are the mainstays of therapy. Here, we present a higher-than-expected incidence of CNS1 in Croatia (6,1 in a million). In the last 31 years, we treated eight CNS1 patients from five families with no reported consanguinity. Four patients are descendants of an isolated enclave in Kosovo with a small gene pool and a high potential for inbreeding. Severe unconjugated hyperbilirubinemia was verified in a neonatal period and PT was initiated. Four patients underwent LT from living-related donors. One of them had unsuccessful hepatocyte transplantation earlier. LT was successful in three patients, and one patient died due to primary graft dysfunction. Four patients are currently treated with 9–12 h daily PT with inconsistent disease control, and gradually increasing bilirubin. One patient developed kernicterus before LT, while others have normal psychomotor development and no neurologic impairment. Genetic testing of the UGT1A1 gene in six patients from three families revealed three different homozygous mutations (c.722_723 delAG, c.717_718 delAG, and c.1021 C >T), all previously described in other populations. There is a possibility of the founder effect as an explanation for the higher incidence of CNS1 in at least a subgroup of Croatians.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatrics, University Hospital Center Zagreb, Zagreb, Croatia.
- School of Medicine, University of Zagreb, Zagreb, Croatia.
- Department of Gastroenterology and Hepatology, University Hospital Center Zagreb, Zagreb, Croatia.
Zitieren
APA
Kovačić Perica, M., Todorić, I., Marčinković, N., Džepina, P., Aničić, M. N., Mrzljak, A., & Vuković, J. (2023). Case report: Crigler-Najjar syndrome type 1 in Croatia—more than a one in a million: a case series. Frontiers in Pediatrics, 11. https://doi.org/10.3389/fped.2023.1276349
Vancouver
Kovačić Perica M, Todorić I, Marčinković N, Džepina P, Aničić MN, Mrzljak A, et al. Case report: Crigler-Najjar syndrome type 1 in Croatia—more than a one in a million: a case series. Frontiers in Pediatrics. 2023;11. doi:10.3389/fped.2023.1276349
BibTeX
@article{KovaiPerica2023,
author = {Kovačić Perica, Matea and Todorić, Ivana and Marčinković, Nedo and Džepina, Petra and Aničić, Mirna Natalija and Mrzljak, Anna and Vuković, Jurica},
title = {Case report: Crigler-Najjar syndrome type 1 in Croatia—more than a one in a million: a case series},
journal = {Frontiers in Pediatrics},
year = {2023},
volume = {11},
doi = {10.3389/fped.2023.1276349}
}
EUVIMED